These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 26057452)
21. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma. Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493 [TBL] [Abstract][Full Text] [Related]
23. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer. Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338 [TBL] [Abstract][Full Text] [Related]
24. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer. Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562 [TBL] [Abstract][Full Text] [Related]
25. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer. Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767 [TBL] [Abstract][Full Text] [Related]
26. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma. Chen Y; Chen J; Liu Y; Li S; Huang P Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771 [TBL] [Abstract][Full Text] [Related]
27. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related]
28. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Hsu CM; Lin PM; Wang YM; Chen ZJ; Lin SF; Yang MY Tumour Biol; 2012 Dec; 33(6):1933-42. PubMed ID: 22811001 [TBL] [Abstract][Full Text] [Related]
30. A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495 [TBL] [Abstract][Full Text] [Related]
31. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. Lian F; Cui Y; Zhou C; Gao K; Wu L PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010 [TBL] [Abstract][Full Text] [Related]
32. Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma. Gao X; Wang Y; Zhao H; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X Oncotarget; 2016 Sep; 7(37):59664-59675. PubMed ID: 27517633 [TBL] [Abstract][Full Text] [Related]
33. Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer. Koshizuka K; Hanazawa T; Kikkawa N; Arai T; Okato A; Kurozumi A; Kato M; Katada K; Okamoto Y; Seki N Cancer Sci; 2017 Aug; 108(8):1681-1692. PubMed ID: 28612520 [TBL] [Abstract][Full Text] [Related]
34. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma. Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584 [TBL] [Abstract][Full Text] [Related]
35. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma. Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419 [TBL] [Abstract][Full Text] [Related]
36. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer. Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988 [TBL] [Abstract][Full Text] [Related]
39. Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset. Wu C; Tong L; Wu C; Chen D; Chen J; Li Q; Jia F; Huang Z Cancer Med; 2020 Apr; 9(8):2631-2642. PubMed ID: 32064753 [TBL] [Abstract][Full Text] [Related]
40. An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma. Citron F; Armenia J; Franchin G; Polesel J; Talamini R; D'Andrea S; Sulfaro S; Croce CM; Klement W; Otasek D; Pastrello C; Tokar T; Jurisica I; French D; Bomben R; Vaccher E; Serraino D; Belletti B; Vecchione A; Barzan L; Baldassarre G Clin Cancer Res; 2017 Jul; 23(14):3769-3780. PubMed ID: 28174235 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]